Johnson & Johnson
Recent News About Johnson & Johnson
-
Oklahoma's governor is worried AG Hunter won't turn $85M opioid settlement over to treasury
NORMAN, Okla. (Legal Newsline) – Oklahoma Gov. Kevin Stitt and two high-ranking lawmakers fear that funds from a recent opioid settlement won't head their way and are asking to intervene, claiming Attorney General Mike Hunter's recent $85 million agreement with Teva Pharmaceutical might violate a new state law. -
Witness list offers a preview of arguments to come in Oklahoma's big opioid trial
NORMAN, Okla. (Legal Newsline) – Not all named witnesses will be called to testify in the two-month-long trial that is beginning its fourth week in Cleveland County Court - a trial that pits the State of Oklahoma against Johnson & Johnson over the abatement of what Oklahoma calls a man-made opioid crisis - but 10 of the more than 160 listed overlap the sides. -
Attorneys for J&J spar with opioids researcher over warning labels during Oklahoma trial
NORMAN, Okla. (Legal Newsline) – Attorneys for Johnson & Johnson on Friday during questioning of a researcher called as a witness by the State attempted to establish that the company’s production of opioid drugs was a government-regulated process with detailed warnings of possible addiction provided. -
J&J finally gets chance to question opioids researcher during Oklahoma trial, fights 'kingpin' remark
NORMAN , Okla. (Legal Newsline) – On his third day of testimony, an opioids researcher was cross-examined by attorneys for Johnson & Johnson as the company defends itself from allegations that it is to blame for the nation's addiction crisis. -
'It keeps changing': Oklahoma's opioid strategy is a 700-year-old English law that used to regulate wandering sheep
NORMAN, Okla. (Legal Newsline) - The opioid trial now underway in a county courthouse in Oklahoma offers the first look at a legal strategy that could result in tens of billions of dollars in liability against the manufacturers and distributors of addictive narcotic painkillers in similar lawsuits nationwide. -
Oklahoma witness in opioid trial says drug users not to blame for addiction crisis
NORMAN, Okla. (Legal Newsline) – During a second day of testimony, an opioid researcher questioned by private attorneys hired by the State of Oklahoma said opioid sellers like Johnson & Johnson sought to shift blame for a prescription drug epidemic onto those not responsible. -
Opioids researcher takes stand to criticize J&J in Oklahoma trial
NORMAN, Okla. (Legal Newsline) – An opioids researcher on Tuesday compared doctors over-prescribing opioids to the breaking of a figurative dam that flooded Oklahoma - and the country - during testimony in an important trial taking place in the state. -
Marketing of J&J's opioids discussed at Oklahoma's big trial
NORMAN, Okla. (Legal Newsline) – A marketing specialist told attorneys for the State of Oklahoma on Monday that the rise in the sales of opioid drugs could be tied to a similar rise over the same period from 1996 to 2017 to deaths from overdose. -
Okla. AG's lawyers offer testimony of addict in big opioid trial, but witness said he never used J&J's products
NORMAN, Okla. (Legal Newsline) – A resident of this small Oklahoma town recounted the hell of his addiction to opioid drugs that began with a legal prescription and then spiraled out of control, testifying in a lawsuit accusing Johnson & Johnson of causing a drug epidemic. -
Oklahoma's hired guns continue to portray Johnson & Johnson as evil to judge in opioid trial
NORMAN, Okla. (Legal Newsline) – On Wednesday, private attorneys hired by the State of Oklahoma on a contingency fee accused Janssen Pharmaceuticals, the drug arm of Johnson & Johnson, of ignoring the warning signs of a nationwide addiction crisis in order to maximize profit. -
In high-profile opioid trial, Johnson & Johnson reminds that its addiction warnings were approved by the FDA
NORMAN, Okla. (Legal Newsline) – Defense attorneys for Johnson & Johnson took over the questioning of Kimberly Deem-Eshleman, southeast regional business director for Janssen Pharmaceuticals and the marketer of its opioid drug Nucynta, attempting to establish that drug labels had provided plenty of warnings about possible addiction. -
Janssen exec questioned for third day by Oklahoma's hired guns in big opioid trial
NORMAN, Okla. (Legal Newsline) – In the closely watched opioid trial taking place in Oklahoma, private attorneys representing the State on Monday sought to portray Johnson & Johnson and its drug subsidiary Janssen Pharmaceuticals as marketing drugs like Nucynta for profit in order to feed an opioid epidemic they ignored. -
OU law prof: If AG's 'improper' opioid lawsuit succeeds, it could 'create a monster'
NORMAN, Okla. (Legal Newsline) - As the opioid trial in Norman, Oklahoma, hits it second week, the public nuisance theory that recently failed in North Dakota will likely succeed in the Sooner State despite it being "improper," a University of Oklahoma legal expert said during an interview. -
State presses Janssen's business director over sales rep notes as OK opioid trial continues
NORMAN (Legal Newsline) – Attorneys representing the State of Oklahoma on Friday displayed slips from salesmen and women representing Johnson & Johnson’s drug subsidiary Janssen Pharmaceuticals in which again and again the reps touted the drug Duragesic as being “low abuse potential.” -
Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on
NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman. -
Father recounts loss of son in Oklahoma Johnson & Johnson opioid trial
NORMAN, Okla. (Legal Newsline) – Fighting back tears, a father who lost his son to an opioid overdose recounted the nightmare during testimony in a trial alleging that Johnson & Johnson flooded the state with addictive drugs for profit. -
Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement
NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed. -
With just one defendant left, Oklahoma struggles to blame J&J for opioid crisis
NORMAN, Okla. (Legal Newsline) – Lawyers for the State of Oklahoma opened a closely watched trial seeking to hold Johnson & Johnson responsible for $17.5 billion in damages over the opioid crisis with a simple refrain: “something happened.” -
Defense: Oklahoma threatening expanded public nuisance theory in this week's high-profile opioid case
NORMAN, Okla. (Legal Newsline) – As the opioid crisis spotlight turns to Norman, Oklahoma, where the state's high profile case against drug companies is expected to get underway tomorrow, defendants in that case are questioning the state's public nuisance theory that has failed dramatically elsewhere. -
Same day, different verdicts: Why do some juries think there is asbestos in talcum powder and others don't?
NEW BRUNSWICK, N.J. (Legal Newsline) – Judges continue to play a crucial role in the sprawling, possibly multibillion-dollar talcum powder litigation facing Johnson & Johnson by choosing how jurors will view the plaintiffs’ key expert.